Miller Wealth Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$25.3K Buy
684
+403
+143% +$23.1K 0.01% 49
2026
Q1
$17K Buy
281
+4
+1% +$233 0.01% 62
2025
Q4
$15K Buy
277
+3
+1% +$144 0.01% 62
2025
Q3
$12.3K Buy
274
+4
+1% +$187 0.01% 71
2025
Q2
$12.5K Buy
270
+3
+1% +$147 0.01% 60
2025
Q1
$16.3K Buy
267
+3
+1% +$175 0.01% 53
2024
Q4
$14.9K Buy
264
+3
+1% +$168 0.01% 48
2024
Q3
$13.9K Buy
261
+3
+1% +$141 0.01% 45
2024
Q2
$10.7K Buy
258
+4
+2% +$179 0.01% 51
2024
Q1
$13.8K Buy
254
+3
+1% +$153 0.01% 48
2023
Q4
$12.9K Buy
251
+2
+0.8% +$105 0.01% 45
2023
Q3
$14.4K Buy
249
+3
+1% +$184 0.01% 42
2023
Q2
$15.7K Sell
246
-5,754
-96% -$386K 0.01% 40
2023
Q1
$196K Buy
6,000
+5,519
+1,147% +$389K 0.95% 8
2022
Q4
$36K Buy
481
+242
+101% +$18.2K 0.03% 33
2022
Q3
$18K Hold
239
0.01% 59
2022
Q2
$18K Buy
239
+2
+0.8% +$152 0.01% 50
2022
Q1
$17K Buy
237
+2
+0.9% +$134 0.01% 54
2021
Q4
$15K Buy
+235
New +$13.8K 0.01% 52

Other funds holding BMY

Miller Wealth Advisors's BMY Position: Q2 2026 in Review

Miller Wealth Advisors increased its Bristol-Myers Squibb (BMY) stake by 143% in Q2 2026, buying an estimated $23.1K and bringing the position to 684 shares worth $25.3K. The position accounts for 0.01% of the portfolio, ranked #49.

Miller Wealth Advisors first reported a position in BMY in Q4 2021 and has held it in 19 quarters since. The position peaked at $196K in Q1 2023. 796 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Miller Wealth Advisors held 684 shares of Bristol-Myers Squibb worth $25.3K as of Q2 2026.
  • Miller Wealth Advisors bought 403 Bristol-Myers Squibb shares in Q2 2026, an estimated $23.1K.
  • Bristol-Myers Squibb made up 0.01% of Miller Wealth Advisors's portfolio in Q2 2026, its #49 holding.
  • Miller Wealth Advisors first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 19 quarters since.
  • Miller Wealth Advisors's Bristol-Myers Squibb position peaked at $196K in Q1 2023.
  • 796 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Miller Wealth Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.